Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa”

457 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 457 results

Large-scale testing (Phase 3)Study completedNCT00199368
What this trial is testing

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Who this might be right for
Parkinson's Disease
Kyowa Kirin, Inc. 1,100
Post-approval studies (Phase 4)Study completedNCT00888186
What this trial is testing

Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

Who this might be right for
Parkinson DiseaseDyskinesias
Uppsala University 5
Testing effectiveness (Phase 2)Study completedNCT04435431
What this trial is testing

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 155
Early research (Phase 1)Study completedNCT03094156
What this trial is testing

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 39
Post-approval studies (Phase 4)Ended earlyNCT03761030
What this trial is testing

L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

Who this might be right for
Major Depressive DisorderDysthymiaDepression
New York State Psychiatric Institute 51
Early research (Phase 1)WithdrawnNCT01500707
What this trial is testing

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

Who this might be right for
Parkinson's Disease
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT00203164
What this trial is testing

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 254
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Large-scale testing (Phase 3)UnknownNCT02615873
What this trial is testing

AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Who this might be right for
Parkinson's Disease
Intec Pharma Ltd. 460
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Testing effectiveness (Phase 2)Study completedNCT07444892
What this trial is testing

Levodopa for Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Emory University 230
Post-approval studies (Phase 4)Study completedNCT00141518
What this trial is testing

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Who this might be right for
Advanced Idiopathic Parkinson's Disease
AbbVie (prior sponsor, Abbott) 77
Testing effectiveness (Phase 2)Study completedNCT00224263
What this trial is testing

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
Xuanwu Hospital, Beijing 360
Not applicableStudy completedNCT06275633
What this trial is testing

Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD

Who this might be right for
Parkinson DiseaseMedicationUPDRS+5 more
University Hospital Bispebjerg and Frederiksberg 68
Testing effectiveness (Phase 2)Study completedNCT01399905
What this trial is testing

High and Low Dose Carbidopa Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Oregon Health and Science University 14
Large-scale testing (Phase 3)Study completedNCT00660673
What this trial is testing

Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson's Disease
AbbVie 262
Large-scale testing (Phase 3)Study completedNCT00466167
What this trial is testing

Pivotal Study in Advanced Parkinsons Disease Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 517
Large-scale testing (Phase 3)Study completedNCT05487300
What this trial is testing

Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

Who this might be right for
Parkinson DiseaseOrthostatic Hypotension
University of Utah 40
Testing effectiveness (Phase 2)Study completedNCT00040209
What this trial is testing

JP-1730 to Treat Parkinson's Disease

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Testing effectiveness (Phase 2)Study completedNCT02834507
What this trial is testing

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease (PD)
Bial - Portela C S.A. 19
Load More Results